Advertisement

Topics

Clinical Ligand Assay Society's Company Profile

17:30 EST 24th November 2017 | BioPortfolio

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and fostering communication and cooperation among individuals in laboratories, in medicine, in academia and industry. Clinical Ligand Assay Society Goals
Ligand Assay Technology
To maintain an organization focused on the diagnostic, therapeutic, analytical and investigative use of ligand tehcnology assays and related methods.
To expand ligand assay technology by promoting education, encouraging basic and clinical research and advancing the practice of ligand assay as applied to biochemical, medical, pharmaceutical, veterinary, agricultural, environmental and industrial sciences.
To sponsor a national meeting, scientific symposia, review course, certification programs, workshops and publications which increase the understanding of ligand assay technology development and application.
To promote cooperation and mutual consultation among members working in laboratories, clinics, hospitals, educational institutions and industry.

Chapter Goals of
Clinical Ligand Assay Society New England

To provide the best educational events in the ligand field.
To provide several networking opportunities during the year.
To work directly with other societies and organizations in planning educational events. Northeast Region Conference is our pre-eminent meeting

Contact

Phone: 508-856-6003
Fax: 508-856-1095
Email: achase739@aol.com


News Articles [1213 Associated News Articles listed on BioPortfolio]

Ligand to Receive $2 Million from WuXi Biologics for Licensing Clinical-Stage anti-PD-1 ...

Ligand Pharmaceuticals IncorporatedTodd Pettingillinvestors@ligand.com(858) 550-7500@Ligand_LGNDorLHABruce Vossbvoss@lhai.com(310) 691-7100 Read more...

New diagnostics tool, the Xpert Ultra assay, improves detection of mycobacterium tuberculosis

(American Society for Microbiology) Researchers have demonstrated a new, improved version of the Xpert MTB/RIF assay, a test for Rifampicin-resistance (RIF-R). The Xpert 'Ultra' assay overcomes the s...

Ligand Enters Into Commercial License and Supply Agreement with Amgen for Rights to Use ...

Ligand Pharmaceuticals IncorporatedTodd Pettingill, 858-550-7500investors@ligand.com@Ligand_LGNDorLHABruce Voss, 310-691-7100bvoss@lhai.com Read more...

Assay Identifies Patients Benefiting from Cancer Immunotherapies

Programmed cell death ligand 1 (PD-L1) has been detected in up to 50% of all human cancers, and has become...

Ligand pens Captisol deal with Amgen

Ligand Pharmaceuticals Inc. licensed Amgen Inc. exclusive global rights to use its Captisol drug delivery technology (which Ligand will supply) in the formulation of AMG330.

Amgen Licenses Ligand's Captisol Technology for AML Candidate AMG 330

Amgen has licensed Ligand Pharmaceuticals’ Captisol ® technology for use in the formulation of AMG 330, the biotech giant’s Phase I acute myeloid leukemia candidate, through an agreement whos...

Ligand to Acquire Crystal Bioscience, Gaining Complementary Antibody Technology

SAN DIEGO & EMERYVILLE, Calif.–(BUSINESS WIRE)–Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and Crystal Bioscience, Inc. (Crystal) announce the signing of a merger agreement wh...

Amgen Licenses Ligand's Captisol Technology for AML Candidate AMG330

Amgen has licensed Ligand Pharmaceuticals’ Captisol ® technology for use in the formulation of AMG 330, the biotech giant’s Phase I acute myeloid leukemia candidate, through an agreement whos...

PubMed Articles [5754 Associated PubMed Articles listed on BioPortfolio]

A European multicientre study on the comparison of HIV-1 viral loads between VERIS HIV-1 Assay and Roche COBAS® TAQMAN® HIV-1 test, Abbott RealTime HIV-1 Assay, and Siemens VERSANT HIV-1 Assay.

Viral load monitoring is essential for patients under treatment for HIV. Beckman Coulter has developed the VERIS HIV-1 Assay for use on the novel, automated DxN VERIS Molecular Diagnostics System.(¥)...

Performance evaluation of the Aptima(®) HCV Quant Dx assay for hepatitis C virus (HCV) RNA detection and quantification in comparison to the Abbott RealTime HCV assay.

The Aptima HCV Quant Dx assay (Aptima) is a real-time transcription-mediated amplification assay CE-approved for the diagnosis and monitoring of hepatitis C virus (HCV) infection.

A European multicentre study on the comparison of HCV viral loads between VERIS HCV assay and COBAS(®) TaqMan(®) HCV Test and RealTime HCV Assay.

Beckman Coulter has developed the VERIS HCV Assay for use on the new fully automated DxN VERIS Molecular Diagnostic System(¥) for HCV viral load monitoring.

Evaluation of a new random-access HBV DNA molecular assay: The VERIS HBV assay.

Detection and quantification of HBV DNA are essential to diagnose chronic HBV infection, monitor the virological response to treatment and the possible selection of resistant viruses in order to tailo...

Detection of pyrazinamide resistance of Mycobacterium tuberculosis using nicotinamide as a surrogate.

Despite the importance of pyrazinamide (PZA) in tuberculosis treatment, PZA susceptibility testing is not routinely performed because of acid pH requirement. The aim of our assay was to evaluate the M...

Clinical Trials [2440 Associated Clinical Trials listed on BioPortfolio]

Clinical Performance Evaluation of DxN CMV Assay

The DxN Cytomegalovirus (CMV) assay is an in vitro diagnostic assay intended as an aid in the management of CMV-infected individuals undergoing antiviral therapy. the purpose of the study ...

Clinical Performance Evaluation of AMH Assay

The Access AMH Assay is an in vitro diagnostic assay intended as an aid for fertility assessment. The purpose of the study is to evaluate the clinical performance of the Access AMH Assay i...

Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

To assess and compare the performance of the HR HPV HC2® test (Qiagen/Digene) and the APTIMA® HPV Assay (Hologic) using LBC Specimens (ThinPrep® Pap Test) for the detection of HPV infec...

Clinical Evaluation of the PROGENSA(R) PCA3 Assay in Men With a Previous Negative Biopsy Result

The objective of this multi-center clinical study is to determine the association of the PCA3 Score with prostate biopsy outcome and validate the assay's performance characteristics in men...

Normal Lacritin Levels in Human Tears- Development of a New Clinical Assay

Purpose: to build a library of normal tear lacritin values by collecting tears from normal adult human subjects and to develop a non-invasive clinical assay for lacritin. Such an assay wi...

Companies [2269 Associated Companies listed on BioPortfolio]

Clinical Ligand Assay Society's

The Clinical Ligand Assay Society's mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitioners, and f...

Clinical Ligand Assay Society

MISSION The Clinical Ligand Assay Society mission is to establish and promote high standards in the science and application of ligand assay technology by encouraging research, educating practitione...

BioAnalab Ltd

BioAnaLab is a leading CRO specialising in analysis of biological therapeutics. We use ligand binding and cell based assays for toxicokinetic/pharmacokinetic and pharmacodynamic analysis, immunopheno...

Ligand Pharmaceuticals

Ligand is an emerging specialty pharmaceutical company that discovers, develops and markets innovative small molecule drugs to address critical, unmet medical needs. Ligand markets four oncology and d...

Ligand Pharmaceuticals Incorporated

Ligand discovers and develops new drugs that address critical unmet medical needs of patients for a broad spectrum of diseases including hepatitis, muscle wasting, Alzheimer's, in...

More Information about "Clinical Ligand Assay Society's" on BioPortfolio

We have published hundreds of Clinical Ligand Assay Society's news stories on BioPortfolio along with dozens of Clinical Ligand Assay Society's Clinical Trials and PubMed Articles about Clinical Ligand Assay Society's for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Clinical Ligand Assay Society's Companies in our database. You can also find out about relevant Clinical Ligand Assay Society's Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Assays
An assay is an analytic procedure for qualitatively assessing or quantitatively measuring the presence or amount or the functional activity of a target entity.  This can be a drug or biochemical substance or a cell in an organism or organic sample. ...


Corporate Database Quicklinks



Searches Linking to this Company Record